Pilar Nos-Mateu

22PUBLICATIONS
143CO-AUTHORS
Gene and molecular therapyEpidemiological modellingDisease surveillancePhysical organic chemistryApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Aug 12, 2026
Impact of Prior Biologic Mechanism of Action on Anti-TNF Effectiveness in Inflammatory Bowel Disease: An ENEIDA Registry Study.

|Jun 08, 2026
Risk of symptomatic leishmaniasis in patients with inflammatory bowel disease receiving biologic therapy in an endemic Mediterranean region: a population-based case-control study.

|Apr 30, 2026
Real-World Effectiveness and Safety of Upadacitinib in Crohn's Disease: Insights From the Eneida Registry.

|Dec 04, 2025

Alejandro Mínguez, Pilar Nos

|Nov 27, 2025
Cytokine Dynamics During Ustekinumab Induction as Predictors of Treatment Response in Crohn's Disease: An Observational Study.

Alejandro Mínguez, Beatriz Mateos, Marisa Iborra

|May 24, 2025
First Documented Case of Successful Dual Therapy With Upadacitinib and Mirikizumab for Multi-Refractory Ulcerative Proctitis.

Daniel Robles de la Osa, Nadia Mileva Semrik, Alejandro Mínguez Sabater

Pageof 4

Frequent Collaborators

7 joint publications

Guillermo Bastida

6 joint publications

Alejandro Mínguez Sabater

6 joint publications

Mariam Aguas

5 joint publications

Marisa Iborra